CLINICAL_TRIALS
trial_result
· 2023-06-07
Clinical Trial Update: Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia [Phase 3]
Summary
Phase 3 clinical trial results updating the efficacy and safety of evinacumab in pediatric patients with Homozygous Familial Hypercholesterolemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2023-06-07